CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 2015—Streck has introduced CD-Chex TdT Plus, a flow cytometry control assayed for TdT, CD1a, CD34, and cCD3. CD-Chex TdT Plus can be used as quality control material for evaluating intracellular and surface antigens including CD1a, CD2, CD4, CD5, CD7, CD8, CD34, cytoplasmic CD3, and nuclear TdT (terminal deoxynucleotidyl transferase). When stained with fluorescent antibodies and analyzed by flow cytometry, the control provides reference values for abnormal cells often found in certain types of hematopoietic neoplasms.
CD-Chex TdT Plus is for research use only and not for use in diagnostic procedures. It offers 30-day open-vial stability and up to 90-day closed-vial stability. CD-Chex TdT Plus is designed for use on BD Biosciences and Beckman Coulter flow cytometry systems.
Streck, 800-843-0912